Cited 148 times in
Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.